Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot, ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

The global ageing population and growing awareness of the benefits of orthobiologic therapy are driving the size of the global orthobiologics market.

Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, is proud to announce the appointment ...

CardioID addresses this gap by offering non-invasive, real-time monitoring without the need for surgery or frequent blood tests ... Sony Corporation, Jana Care, Medtronic, and Volcano. Additionally, ...

The global soft tissue repair market is on track for substantial growth, with an estimated valuation of USD 6,992.8 million ...

Austin, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The S&S Insider report indicates that, “The Biomaterials Market was valued at USD 178.08 billion in 2023 and is expected to reach USD 650.56 billion by 2032, ...